Dapagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of safety data from phase IIb/III clinical trials
- Serge Jabbour*
- , Jochen Seufert
- , Andre Scheen
- , Clifford J. Bailey
- , Cathrina Karup
- , Anna M. Langkilde
*Corresponding author for this work
- Thomas Jefferson University
- Universitats Klinikum Freiburg und Medizinische Fakultat
- Université de Liège
- AstraZeneca Sweden
Research output: Contribution to journal › Article › peer-review
135
Link opens in a new tab
Citations
(Scopus)
112
Downloads
(Pure)